Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
March-2018 Volume 41 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2018 Volume 41 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside inhibits septic serum‑induced inflammatory injury via interfering with the ROS‑MAPK‑NF‑κB signaling pathway in pulmonary aortic endothelial cells

  • Authors:
    • Wenqiang Li
    • Ruifang Sun
    • Sumei Zhou
    • Jinluan Ma
    • Yingguang Xie
    • Bingcan Xu
    • Huibao Long
    • Keqin Luo
    • Kuaifa Fang
  • View Affiliations / Copyright

    Affiliations: Intensive Care Unit, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China, Department of Joint Surgery, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China, Department of Emergency, Sun Yat‑Sen Memorial Hospital, Sun Yat‑Sen University, Guangzhou, Guangdong 510120, P.R. China, Emergency of ICU, Huiyang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
  • Pages: 1643-1650
    |
    Published online on: December 19, 2017
       https://doi.org/10.3892/ijmm.2017.3329
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Sepsis is characterized by injury to the microvasculature and the microvascular endothelial cells, leading to barrier dysfunction. However, the specific role of injury in septic endothelial barrier dysfunction remains to be elucidated. In the present study, it was hypothesized that endothelial cell inflammatory injury is likely required for barrier dysfunction under septic conditions in vitro. 2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside (TSG), a compound extracted from Chinese herbs, is able to inhibit the inflammatory injury of septic‑serum in endothelial cells. In the present study, cell viability was assayed by CCK‑8 method; mRNA and protein expression was identified by RT‑qPCR, western blot or Elisa, respectively and the production of reactive oxygen species was observed by a fluorescence microscope. The present study indicated that septic serum significantly decreased the cell viability of pulmonary aortic endothelial cells (PAECs) following co‑cultivation for 6 h, which occurred in a time‑dependent manner. TSG notably increased the viability of PAECs in a time‑ and concentration‑dependent manner. Further investigations revealed that septic serum increased the secretion of interleukin (IL)‑1β, IL‑6 and C‑reactive protein in PAECs, whereas pretreatment with TSG significantly decreased the secretion of these inflammatory factors. These data indicated that septic serum increased inflammatory injury to the PAECs, and TSG decreased this injury via the reactive oxygen species‑mitogen‑activated protein kinase‑nuclear factor‑κB signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Churpek MM, Snyder A, Han X, Sokol S, Pettit N, Howell MD and Edelson DP: Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit. Am J Respir Crit Care Med. 195:906–911. 2017. View Article : Google Scholar

2 

Colbert JF, Schmidt EP, Faubel S and Ginde AA: Severe sepsis outcomes among hospitalizations with inflammatory bowel disease. Shock. 47:128–131. 2017. View Article : Google Scholar

3 

Kanashiro A, Sônego F, Ferreira RG, Castanheira FV, Leite CA, Borges VF, Nascimento DC, Cólon DF, Alves-Filho JC, Ulloa L and Cunha FQ: Therapeutic potential and limitations of cholinergic anti-inflammatory pathway in sepsis. Pharmacol Res. 117:1–8. 2017. View Article : Google Scholar

4 

Martin JB and Badeaux JE: Interpreting laboratory tests in infection: Making sense of biomarkers in sepsis and systemic inflammatory response syndrome for intensive care unit patients. Crit Care Nurs Clin North Am. 29:119–130. 2017. View Article : Google Scholar : PubMed/NCBI

5 

Md Ralib A, Mat Nor MB and Pickering JW: Plasma neutrophil gelatinase-associated lipocalin diagnosed acute kidney injury in patients with systemic inflammatory disease and sepsis. Nephrology (Carlton). 22:412–419. 2017. View Article : Google Scholar

6 

Arcêncio L and Evora PR: The lack of clinical applications would be the cause of low interest in an endothelial dysfunction classification. Arq Bras Cardiol. 108:97–99. 2017.In English, Portuguese. PubMed/NCBI

7 

Downey RM, Liao P, Millson EC, Quyyumi AA, Sher S and Park J: Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease. Am J Physiol Renal Physiol. 312:F917–F924. 2017. View Article : Google Scholar : PubMed/NCBI

8 

Graw JA, Yu B, Rezoagli E, Warren HS, Buys ES, Bloch DB and Zapol WM: Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension. Am J Physiol Heart Circ Physiol. 312:H1120–H1127. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Hashemi M, Heshmat-Ghahdarijani K, Zarean E, Baktash F and Mortazavi ZS: Evaluation of the effect of high-dose folic acid on endothelial dysfunction in pre-eclamptic patients: A randomized clinical trial. J Res Med Sci. 21:1142016. View Article : Google Scholar

10 

Rothenbach PA, Dahl B, Schwartz JJ, O'Keefe GE, Yamamoto M, Lee WM, Horton JW, Yin HL and Turnage RH: Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol (1985). 96:25–31. 2004. View Article : Google Scholar

11 

Tsukamoto M, Tampo Y, Sawada M and Yonaha M: Paraquat-induced membrane dysfunction in pulmonary microvascular endothelial cells. Pharmacol Toxicol. 86:102–109. 2000. View Article : Google Scholar

12 

Tsukamoto M, Tampo Y, Sawada M and Yonaha M: Paraquat-induced oxidative stress and dysfunction of the glutathione redox cycle in pulmonary microvascular endothelial cells. Toxicol Appl Pharmacol. 178:82–92. 2002. View Article : Google Scholar : PubMed/NCBI

13 

Farley KS, Wang LF, Law C and Mehta S: Alveolar macrophage inducible nitric oxide synthase-dependent pulmonary micro-vascular endothelial cell septic barrier dysfunction. Microvasc Res. 76:208–216. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Chang MJ, Xiao JH, Wang Y, Yan YL, Yang J and Wang JL: 2,3,5,4′-Tetrahydroxystilbene-2-O-beta-D-glucoside improves gastrointestinal motility disorders in STZ-induced diabetic mice. PLoS One. 7:e502912012. View Article : Google Scholar

15 

He H, Wang S, Tian J, Chen L, Zhang W, Zhao J, Tang H, Zhang X and Chen J: Protective effects of 2,3,5,4′-tetrahydro xystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways. Eur J Pharmacol. 767:175–182. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Lin CL, Hsieh SL, Leung W, Jeng JH, Huang GC, Lee CT and Wu CC: 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-gluc oside suppresses human colorectal cancer cell metastasis through inhibiting NF-κB activation. Int J Oncol. 49:629–638. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Ling S, Duan J, Ni R and Xu JW: 2,3,5,4′-Tetrahydroxystilbene -2-O-β-D-glucoside promotes expression of the longevity gene klotho. Oxid Med Cell Longev. 2016:31282352016. View Article : Google Scholar

18 

Ling S and Xu JW: Biological Activities of 2,3,5,4′-tetrah ydroxystilbene-2-O-β-D-glucoside in antiaging and anti-aging-related disease treatments. Oxid Med Cell Longev. 2016:49732392016. View Article : Google Scholar

19 

Peng Y, Zeng Y, Xu J, Huang XL, Zhang W and Xu XL: PPAR-gamma is involved in the protective effect of 2,3,4′,5-tetra-hydroxystilbene-2-O-beta-D-glucoside against cardiac fibrosis in pressure-overloaded rats. Eur J Pharmacol. 791:105–114. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Lambertucci F, Motiño O, Villar S, Rigalli JP, de Luján Alvarez M, Catania VA, Martín-Sanz P, Carnovale CE, Quiroga AD, Francés DE and Ronco MT: Benznidazole, the trypanocidal drug used for chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis. Toxicol Appl Pharmacol. 315:12–22. 2017. View Article : Google Scholar

21 

Li HR, Liu J, Zhang SL, Luo T, Wu F, Dong JH, Guo YJ and Zhao L: Corilagin ameliorates the extreme inflammatory status in sepsis through TLR4 signaling pathways. BMC Complement Altern Med. 17:182017. View Article : Google Scholar : PubMed/NCBI

22 

Park SY, Jin ML, Wang Z, Park G and Choi YW: 2,3,4′,5-tetrahyd roxystilbene-2-O-β-d-glucoside exerts anti-inflammatory effects on lipopolysaccharide-stimulated microglia by inhibiting NF-κB and activating AMPK/Nrf2 pathways. Food Chem Toxicol. 97:159–167. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Zhang M, Yu LM, Zhao H, Zhou XX, Yang Q, Song F, Yan L, Zhai ME, Li BY, Zhang B, et al: 2,3,5,4′-Tetrahydroxystilbe ne-2-O-β-D-glucoside protects murine hearts against ischemia/reperfusion injury by activating Notch1/Hes1 signaling and attenuating endoplasmic reticulum stress. Acta Pharmacol Sin. 38:317–330. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Zhang W, Chen XF, Huang YJ, Chen QQ, Bao YJ and Zhu W: 2,3,4′,5-Tetrahydroxystilbene-2-O-β-D-glucoside inhibits angiotensin II-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway. Clin Exp Pharmacol Physiol. 39:429–437. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Zhao J, Xu S, Song F, Nian L, Zhou X and Wang S: 2,3,5,4′-tetr ahydroxystilbene-2-O-β-D-glucoside protects human umbilical vein endothelial cells against lysophosphatidylcholine-induced apoptosis by upregulating superoxide dismutase and glutathione peroxidase. IUBMB Life. 66:711–722. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Peng G, Wen X, Shi Y, Jiang Y, Hu G, Zhou Y and Ran P: Development of a new method for the isolation and culture of pulmonary arterial endothelial cells from rat pulmonary arteries. J Vasc Res. 50:468–477. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Niwa H, Ogawa Y, Kido Y, Abe Y, Kobayashi M, Mori T and Tanaka T: The rate of lipid oxidation in septic rat models. Jpn J Surg. 19:439–445. 1989. View Article : Google Scholar : PubMed/NCBI

28 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

29 

Cepinskas G and Wilson JX: Inflammatory response in micro-vascular endothelium in sepsis: Role of oxidants. J Clin Biochem Nutr. 42:175–184. 2008. View Article : Google Scholar : PubMed/NCBI

30 

Garrean S, Gao XP, Brovkovych V, Shimizu J, Zhao YY and Vogel SM: Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol. 177:4853–4860. 2006. View Article : Google Scholar : PubMed/NCBI

31 

McCuskey RS, Nishida J, McDonnell D, Baker GL, Urbaschek R and Urbaschek B: Effect of immunoglobulin G on the hepatic microvascular inflammatory response during sepsis. Shock. 5:28–33. 1996. View Article : Google Scholar : PubMed/NCBI

32 

Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A and Roussos C: Angiopoietin-2 is increased in severe sepsis: Correlation with inflammatory mediators. Crit Care Med. 35:199–206. 2007. View Article : Google Scholar

33 

Biegańska-Hensoldt S and Rosolowska-Huszcz D: Polyphenols in preventing endothelial dysfunction. Postepy Hig Med Dosw (Online). 71:227–235. 2017. View Article : Google Scholar

34 

Moussa MD, Santonocito C, Fagnoul D, Donadello K, Pradier O, Gaussem P, De Backer D and Vincent JL: Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells. Intensive Care Med. 41:231–238. 2015. View Article : Google Scholar

35 

Schlichting DE, Waxman AB, O'Brien LA, Wang T, Naum CC, Rubeiz GJ, Um SL, Williams M and Yan SC: Circulating endothelial and endothelial progenitor cells in patients with severe sepsis. Microvasc Res. 81:216–221. 2011. View Article : Google Scholar

36 

Lush CW and Kvietys PR: Microvascular dysfunction in sepsis. Microcirculation. 7:83–101. 2000. View Article : Google Scholar : PubMed/NCBI

37 

Vincent JL and De Backer D: Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care. 9(Suppl 4): S9–S12. 2005. View Article : Google Scholar : PubMed/NCBI

38 

Nishida J, Ekataksin W, McDonnell D, Urbaschek R, Urbaschek B and McCuskey RS: Ethanol exacerbates hepatic microvascular dysfunction, endotoxemia, and lethality in septic mice. Shock. 1:413–418. 1994. View Article : Google Scholar : PubMed/NCBI

39 

Armour J, Tyml K, Lidington D and Wilson JX: Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol (1985). 90:795–803. 2001. View Article : Google Scholar

40 

De Blasi RA, Palmisani S, Alampi D, Mercieri M, Romano R, Collini S and Pinto G: Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock. Intensive Care Med. 31:1661–1668. 2005. View Article : Google Scholar : PubMed/NCBI

41 

Constantino L, Goncalves RC, Giombelli VR, Tomasi CD, Vuolo F, Kist LW, de Oliveira GM, Pasquali MA, Bogo MR, Mauad T, et al: Regulation of lung oxidative damage by endogenous superoxide dismutase in sepsis. Intensive Care Med Exp. 2:172014. View Article : Google Scholar

42 

Schwalm MT, Pasquali M, Miguel SP, Dos Santos JP, Vuolo F, Comim CM, Petronilho F, Quevedo J, Gelain DP, Moreira JC, et al: Acute brain inflammation and oxidative damage are related to long-term cognitive deficits and markers of neurodegeneration in sepsis-survivor rats. Mol Neurobiol. 49:380–385. 2014. View Article : Google Scholar

43 

Taner G, Aydin S, Bacanli M, Sarıgöl Z, Sahin T, Başaran AA and Başaran N: Modulating effects of pycnogenol® on oxidative stress and DNA damage induced by sepsis in rats. Phytother Res. 28:1692–1700. 2014. View Article : Google Scholar : PubMed/NCBI

44 

O'Sullivan AW, Wang JH and Redmond HP: NF-kappaB and p38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy. J Surg Res. 152:46–53. 2009. View Article : Google Scholar

45 

Ronco MT, Manarin R, Francés D, Serra E, Revelli S and Carnovale C: Benznidazole treatment attenuates liver NF-κB activity and MAPK in a cecal ligation and puncture model of sepsis. Mol Immunol. 48:867–873. 2011. View Article : Google Scholar : PubMed/NCBI

46 

Song GY, Chung CS, Chaudry IH and Ayala A: Immune suppression in polymicrobial sepsis: differential regulation of Th1 and Th2 responses by p38 MAPK. J Surg Res. 91:141–146. 2000. View Article : Google Scholar : PubMed/NCBI

47 

Song GY, Chung CS, Jarrar D, Chaudry IH and Ayala A: Evolution of an immune suppressive macrophage phenotype as a product of P38 MAPK activation in polymicrobial sepsis. Shock. 15:42–48. 2001. View Article : Google Scholar : PubMed/NCBI

48 

Song GY, Chung CS, Jarrar D, Cioffi WG and Ayala A: Mechanism of immune dysfunction in sepsis: Inducible nitric oxide-meditated alterations in p38 MAPK activation. J Trauma. 53:276–2832. 2002. View Article : Google Scholar : PubMed/NCBI

49 

Sun Y, Li YH, Wu XX, Zheng W, Guo ZH, Li Y, Chen T, Hua ZC and Xu Q: Ethanol extract from Artemisia vestita, a traditional Tibetan medicine, exerts anti-sepsis action through down-regulating the MAPK and NF-kappaB pathways. Int J Mol Med. 17:957–962. 2006.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li W, Sun R, Zhou S, Ma J, Xie Y, Xu B, Long H, Luo K and Fang K: 2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside inhibits septic serum‑induced inflammatory injury via interfering with the ROS‑MAPK‑NF‑κB signaling pathway in pulmonary aortic endothelial cells. Int J Mol Med 41: 1643-1650, 2018.
APA
Li, W., Sun, R., Zhou, S., Ma, J., Xie, Y., Xu, B. ... Fang, K. (2018). 2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside inhibits septic serum‑induced inflammatory injury via interfering with the ROS‑MAPK‑NF‑κB signaling pathway in pulmonary aortic endothelial cells. International Journal of Molecular Medicine, 41, 1643-1650. https://doi.org/10.3892/ijmm.2017.3329
MLA
Li, W., Sun, R., Zhou, S., Ma, J., Xie, Y., Xu, B., Long, H., Luo, K., Fang, K."2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside inhibits septic serum‑induced inflammatory injury via interfering with the ROS‑MAPK‑NF‑κB signaling pathway in pulmonary aortic endothelial cells". International Journal of Molecular Medicine 41.3 (2018): 1643-1650.
Chicago
Li, W., Sun, R., Zhou, S., Ma, J., Xie, Y., Xu, B., Long, H., Luo, K., Fang, K."2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside inhibits septic serum‑induced inflammatory injury via interfering with the ROS‑MAPK‑NF‑κB signaling pathway in pulmonary aortic endothelial cells". International Journal of Molecular Medicine 41, no. 3 (2018): 1643-1650. https://doi.org/10.3892/ijmm.2017.3329
Copy and paste a formatted citation
x
Spandidos Publications style
Li W, Sun R, Zhou S, Ma J, Xie Y, Xu B, Long H, Luo K and Fang K: 2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside inhibits septic serum‑induced inflammatory injury via interfering with the ROS‑MAPK‑NF‑κB signaling pathway in pulmonary aortic endothelial cells. Int J Mol Med 41: 1643-1650, 2018.
APA
Li, W., Sun, R., Zhou, S., Ma, J., Xie, Y., Xu, B. ... Fang, K. (2018). 2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside inhibits septic serum‑induced inflammatory injury via interfering with the ROS‑MAPK‑NF‑κB signaling pathway in pulmonary aortic endothelial cells. International Journal of Molecular Medicine, 41, 1643-1650. https://doi.org/10.3892/ijmm.2017.3329
MLA
Li, W., Sun, R., Zhou, S., Ma, J., Xie, Y., Xu, B., Long, H., Luo, K., Fang, K."2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside inhibits septic serum‑induced inflammatory injury via interfering with the ROS‑MAPK‑NF‑κB signaling pathway in pulmonary aortic endothelial cells". International Journal of Molecular Medicine 41.3 (2018): 1643-1650.
Chicago
Li, W., Sun, R., Zhou, S., Ma, J., Xie, Y., Xu, B., Long, H., Luo, K., Fang, K."2,3,5,4'‑Tetrahydroxystilbene‑2‑O‑β‑D‑glucoside inhibits septic serum‑induced inflammatory injury via interfering with the ROS‑MAPK‑NF‑κB signaling pathway in pulmonary aortic endothelial cells". International Journal of Molecular Medicine 41, no. 3 (2018): 1643-1650. https://doi.org/10.3892/ijmm.2017.3329
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team